Results 101 to 110 of about 87,711 (271)
Chemistry – A European Journal, EarlyView.The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik +3 more
wiley +1 more source
Cancer Nexus, EarlyView.Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk +2 more
wiley +1 more source
, 2005 We report the case of a 52-yr-old man with metastatic lung adenocarcinoma who developed tumor lysis syndrome after administration of zoledronic acid. Tumor lysis syndrome in solid tumors and the antitumor effect of the zolendronic acid are discussed in ...
Gullu, I +5 more
core +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.ISB 2001 is a trispecific antibody that binds to two tumor‐associated antigens (TAA), CD38 and BCMA, and crosslinks to CD3 on T cells resulting in T cell‐mediated cytotoxicity of tumor cells expressing these TAAs. ISB 2001 is currently being tested in relapsed and/or refractory multiple myeloma (RRMM) patients in the first‐in‐human (FIH) TRIgnite‐1 ...
Vinu Chandralayam Ayyappa Menon +11 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.The minimal anticipated biological effect level (MABEL) approach to first‐in‐human (FIH) dose calculation can lead to long dose‐escalation periods before observing clinical activity. We used a novel ex vivo MABEL approach to calculate the FIH starting dose for forimtamig, a T‐cell bispecific antibody under investigation for the treatment of relapsed ...
Thomas E. Kraft +16 more
wiley +1 more source
Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology
Exploration, EarlyView.Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen +8 more
wiley +1 more source
Annals of Internal Medicine: Clinical CasesMalignant ascites is the accumulation of fluid-containing malignant cells in the peritoneal cavity, most often due to solid organ tumors. Rarely, abdominal lymphoma may also cause malignant ascites and masquerade as a colorectal tumor on imaging.
Garrett L. Healy +2 more
doaj +1 more source
Head &Neck, EarlyView.ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Update on tumor lysis syndrome management
Journal of Health Science and Medical Research (JHSMR), 2006 Tumor lysis syndrome (TLS) is an oncologic emergency resulting from rapid cancer cell destruction as a result of spontaneous tumor necrosis or treatment-related cell lysis.
P Angsuwatcharakon, P Sunpaweravong
doaj
Metastatic adult neuroblastoma with spontaneous tumor lysis syndrome
Autopsy and Case Reports, 2021 Neuroblastoma (NB) is a solid tumor of the sympathetic nervous system, most commonly found in childhood, standing for 7% of all pediatric malignancies. The incidence in adults is markedly smaller: 1 case per 10 million adults per year. We report the case
Tarsila Vieceli +3 more
doaj